MTM-H-001 Injection: Clinical Trials

2 trials of MTM-H-001 Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Not yet recruiting 2

Follow MTM-H-001 Injection: new trials by email Literature Review of MTM-H-001 Injection trials Research Report on MTM-H-001 Injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases
MTM-H-001 Injection - Systemic Lupus Erthematosus (SLE), Lupus Nephritis (LN)
Not applicableNot yet recruitingBeijing GoBroad Hospital752026-06-012026-05-18
A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies
MTM-H-001 Injection - Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Follicular
Not applicableNot yet recruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences692026-03-012026-03-17

Conditions studied

Arthritis, Rheumatoid (1)  ·  Immunoglobulin G4-Related Disease (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lupus Nephritis (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Multiple Sclerosis (1)  ·  Myasthenia Gravis (1)

Sponsors

Beijing GoBroad Hospital (1)  ·  Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)

Countries

China (2)

Top investigators

Jing Pan, Ph.D (1)  ·  Ning Li, Ph.D (1)